查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1722528

2025 年至 2033 年黄斑部病变治疗市场报告（按类型、疾病阶段、给药途径、最终用户和地区划分）

Macular Degeneration Treatment Market Report by Type, Stage of Disease, Route of Administration, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

2024年全球黄斑部病变治疗市场规模达99亿美元。展望未来， IMARC Group预计到2033年市场规模将达到158亿美元，2025-2033年期间的成长率（CAGR）为5.28%。市场的主要驱动力是人群中老年性黄斑部病变和肥胖症的发病率不断上升、久坐不动的生活方式日益盛行、智能设备的快速使用以及医疗保健基础设施的显着改善，尤其是在发展中经济体。

黄斑部病变是一种影响眼睛的神经退化性眼部疾病，会导致视野中心视力模糊或丧失。其特征是视野中存在盲点、视觉扭曲以及在低光源条件下无法看清东西。一些常用的黄斑部病变治疗技术包括抗血管新生药物、光动力雷射疗法、隐形眼镜和过渡镜片。雷射治疗包括将专门的隐形眼镜插入眼睛的患处，并用雷射将患处和血管封住。抗血管新生药物用于防止血管阻塞和渗漏。及时治疗黄斑部病变有助于增强视力并最大限度地降低慢性失明的风险。

黄斑部病变治疗市场趋势：

人群中年龄相关性黄斑部病变和肥胖症发病率的增加是推动市场成长的关键因素之一。饮食习惯的改变和久坐不动的生活方式的日益盛行导致了黄斑部病变的发展。此外，智慧型手机、笔记型电脑和电视的使用率不断增加，导致萤幕使用时间延长和过长，这也影响了这种疾病的发生。此外，涉及将腺相关病毒（AAV）注射到体内以防止异常血管发育的视网膜基因疗法的发展正在推动市场成长。与此相符的是，医疗保健基础设施的显着改善对市场成长产生了积极影响。其他因素，包括为开发创新有效药物而进行的广泛研究和开发 (R&D) 活动，以及政府为促进公共健康而实施的各种倡议，预计将推动市场成长。

本报告回答的关键问题

  • 2024 年全球黄斑部病变治疗市场规模？ 2025 年至 2033 年期间全球黄斑部病变治疗市场的预期成长率为何？
  • 推动全球黄斑部病变治疗市场发展的关键因素有哪些？
  • COVID-19 对全球黄斑部病变治疗市场有何影响？
  • 根据类型，全球黄斑部病变治疗市场是如何分布的？
  • 根据疾病的阶段，全球黄斑部病变治疗市场是如何分布的？
  • 根据给药途径，全球黄斑部病变治疗市场如何分布？
  • 根据最终用户，全球黄斑部病变治疗市场的分布如何？
  • 全球黄斑部病变治疗市场的主要区域有哪些？
  • 全球黄斑部病变治疗市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球黄斑部病变治疗市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场细分：依类型

  • 干性老年黄斑部病变
  • 湿性老年性黄斑部病变

第七章：市场区隔：依疾病阶段

  • 早期
  • 中级阶段
  • 后期

第八章：市场区隔：依行政途径

  • 静脉途径
  • 玻璃体内途径

第九章：市场区隔：依最终用户

  • 医院
  • 门诊手术中心
  • 其他的

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Aerie Pharmaceuticals Inc.
    • Bausch Health Companies Inc.
    • Bayer AG
    • F. Hoffmann-La Roche Ltd
    • Iveric Bio Inc.
    • Novartis AG
    • Panoptica
    • Pfizer Inc.
    • Phio Pharmaceuticals
    • Regeneron Pharmaceuticals Inc.
    • Regenxbio Inc.
    • Santen Pharmaceutical Co. Ltd.
Product Code: SR112025A5118

The global macular degeneration treatment market size reached USD 9.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.8 Billion by 2033, exhibiting a growth rate (CAGR) of 5.28% during 2025-2033. The market is majorly driven by the increasing incidences of age-related macular degeneration and obesity among the masses, growing prevalence of sedentary lifestyles, rapid utilization of smart devices, and significant improvements in the healthcare infrastructure, particularly in developing economies.

Macular degeneration is a neurodegenerative ocular disorder that affects the eyes and causes blurred or loss of vision in the center of the visual field. It is characterized by blind spots in the field of vision, visual distortions and inability to see in low light conditions. Some of the commonly used therapeutic techniques for macular degeneration includes anti-angiogenic drugs, photodynamic laser therapies, contact lenses and transitional lenses. Laser therapy involves the insertion of specialized contact lenses into the affected are of the eye, which are sealed by lasers along with the blood vessels. Anti-angiogenic drugs are used for preventing blockages and leakages in the blood vessels. Timely treatment of macular degeneration treatment can aid in enhancing vision and minimizing the risks of developing chronic blindness.

Macular Degeneration Treatment Market Trends:

The increasing incidences of age-related macular degeneration and obesity among the masses is one of the key factors driving the market growth. The changing dietary patterns and the rising adoption of sedentary lifestyles is leading to the development of macular degeneration. Additionally, the increasing utilization of smartphones, laptops and television, which is leading to prolonged and excessive screen time is also impacting the occurrence of the disorder. Moreover, the development of retinal gene therapies that involves the injection of adeno-associated virus (AAV) into the body for preventing the development of abnormal blood vessels is providing a thrust to the market growth. In line with this, significant improvements in the healthcare infrastructure is positively impacting the market growth. Other factors, including extensive research and development (R&D) activities for the development of innovative and effective drugs, along with the implementation of various government initiatives for promoting public health, are anticipated to drive the market toward growth.

Key Market Segmentation:

Breakup by Type:

  • Dry Age-related Macular Degeneration
  • Wet Age-related Macular Degeneration

Breakup by Stage of Disease:

  • Early Stage
  • Intermediate Stage
  • Late Stage

Breakup by Route of Administration:

  • Intravenous Route
  • Intravitreal Route

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Center
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Aerie Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd, Iveric Bio Inc., Novartis AG, Panoptica, Pfizer Inc., Phio Pharmaceuticals, Regeneron Pharmaceuticals Inc., Regenxbio Inc. and Santen Pharmaceutical Co. Ltd.

Key Questions Answered in This Report

  • 1.What was the size of the global macular degeneration treatment market in 2024?
  • 2.What is the expected growth rate of the global macular degeneration treatment market during 2025-2033?
  • 3.What are the key factors driving the global macular degeneration treatment market?
  • 4.What has been the impact of COVID-19 on the global macular degeneration treatment market?
  • 5.What is the breakup of the global macular degeneration treatment market based on the type?
  • 6.What is the breakup of the global macular degeneration treatment market based on the stage of disease?
  • 7.What is the breakup of the global macular degeneration treatment market based on the route of administration?
  • 8.What is the breakup of the global macular degeneration treatment market based on the end user?
  • 9.What are the key regions in the global macular degeneration treatment market?
  • 10.Who are the key players/companies in the global macular degeneration treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Macular Degeneration Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Dry Age-related Macular Degeneration
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Wet Age-related Macular Degeneration
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Stage of Disease

  • 7.1 Early Stage
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Intermediate Stage
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Late Stage
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Intravenous Route
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Intravitreal Route
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgical Center
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Aerie Pharmaceuticals Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 Bausch Health Companies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 F. Hoffmann-La Roche Ltd
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Iveric Bio Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Novartis AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Panoptica
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Pfizer Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Phio Pharmaceuticals
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Regeneron Pharmaceuticals Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Regenxbio Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Santen Pharmaceutical Co. Ltd.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Macular Degeneration Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Macular Degeneration Treatment Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Macular Degeneration Treatment Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Macular Degeneration Treatment Market: Breakup by Type (in %), 2024
  • Figure 5: Global: Macular Degeneration Treatment Market: Breakup by Stage of Disease (in %), 2024
  • Figure 6: Global: Macular Degeneration Treatment Market: Breakup by Route of Administration (in %), 2024
  • Figure 7: Global: Macular Degeneration Treatment Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Macular Degeneration Treatment Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Macular Degeneration Treatment (Dry Age-related Macular Degeneration) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Macular Degeneration Treatment (Dry Age-related Macular Degeneration) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Macular Degeneration Treatment (Wet Age-related Macular Degeneration) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Macular Degeneration Treatment (Wet Age-related Macular Degeneration) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Macular Degeneration Treatment (Early Stage) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Macular Degeneration Treatment (Early Stage) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Macular Degeneration Treatment (Intermediate Stage) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Macular Degeneration Treatment (Intermediate Stage) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Macular Degeneration Treatment (Late Stage) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Macular Degeneration Treatment (Late Stage) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Macular Degeneration Treatment (Intravenous Route) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Macular Degeneration Treatment (Intravenous Route) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Macular Degeneration Treatment (Intravitreal Route) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Macular Degeneration Treatment (Intravitreal Route) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Macular Degeneration Treatment (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Macular Degeneration Treatment (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Macular Degeneration Treatment (Ambulatory Surgical Center) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Macular Degeneration Treatment (Ambulatory Surgical Center) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Macular Degeneration Treatment (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Macular Degeneration Treatment (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: North America: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: North America: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: United States: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: United States: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Canada: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Canada: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Asia-Pacific: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Asia-Pacific: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: China: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: China: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Japan: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Japan: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: India: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: India: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: South Korea: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: South Korea: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Australia: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Australia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Indonesia: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Indonesia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Others: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Europe: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Europe: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Germany: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Germany: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: France: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: France: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: United Kingdom: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: United Kingdom: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Italy: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Italy: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Spain: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Spain: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Russia: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Russia: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Others: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Latin America: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Latin America: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Brazil: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Brazil: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Mexico: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Mexico: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Others: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Others: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Middle East and Africa: Macular Degeneration Treatment Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Middle East and Africa: Macular Degeneration Treatment Market: Breakup by Country (in %), 2024
  • Figure 77: Middle East and Africa: Macular Degeneration Treatment Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Global: Macular Degeneration Treatment Industry: SWOT Analysis
  • Figure 79: Global: Macular Degeneration Treatment Industry: Value Chain Analysis
  • Figure 80: Global: Macular Degeneration Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Macular Degeneration Treatment Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Macular Degeneration Treatment Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Macular Degeneration Treatment Market Forecast: Breakup by Stage of Disease (in Million USD), 2025-2033
  • Table 4: Global: Macular Degeneration Treatment Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 5: Global: Macular Degeneration Treatment Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Macular Degeneration Treatment Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Macular Degeneration Treatment Market: Competitive Structure
  • Table 8: Global: Macular Degeneration Treatment Market: Key Players